Sblendorio Glenn insider trades
Sblendorio Glenn has filed 35 Form 4s with the SEC that we hold, for ISEE (Chief Executive Officer, Director), FOLD (Director), Mineralys Therapeutics, Inc. (MLYS) (Director) and ICPT (Director), among 5 companies in all. Across all of them we count 0 purchases worth $0 and 16 sales worth $5.4M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 50,000 shares of ISEE worth $1.2M, dated 2022-11-02. The first filing on our record is dated 2021-12-13 and the latest 2026-06-18.
ISEE
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-12-13 | S, sale reported on Form 4 | 8,293 | $122.2K | 2021-12-14 |
| 2021-12-20 | S, sale reported on Form 4 | 18,524 | $286.0K | 2021-12-21 |
| 2021-12-22 | S, sale reported on Form 4 | 22,163 | $365.7K | 2021-12-27 |
| 2021-12-23 | S, sale reported on Form 4 | 31,084 | $527.2K | 2021-12-27 |
| 2021-12-27 | S, sale reported on Form 4 | 5,229 | $87.0K | 2021-12-27 |
| 2021-12-30 | S, sale reported on Form 4 | 100 | $1.7K | 2022-01-03 |
| 2021-12-31 | S, sale reported on Form 4 | 801 | $13.6K | 2022-01-03 |
| 2022-03-18 | S, sale reported on Form 4 | 3,479 | $59.1K | 2022-03-22 |
| 2022-03-25 | S, sale reported on Form 4 | 18,775 | $320.3K | 2022-03-29 |
| 2022-03-30 | S, sale reported on Form 4 | 1,213 | $20.6K | 2022-04-01 |
| 2022-03-31 | S, sale reported on Form 4 | 1,400 | $23.8K | 2022-04-01 |
| 2022-04-01 | S, sale reported on Form 4 | 40,756 | $713.2K | 2022-04-01 |
| 2022-04-04 | S, sale reported on Form 4 | 50,000 | $938.0K | 2022-04-06 |
| 2022-11-02 | S, sale reported on Form 4 | 50,000 | $1.2M | 2022-11-04 |
| 2022-12-19 | S, sale reported on Form 4 | 19,457 | $418.5K | 2022-12-20 |
| 2023-01-03 | S, sale reported on Form 4 | 17,447 | $350.0K | 2023-01-04 |
FOLD
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Mineralys Therapeutics, Inc. (MLYS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
ICPT
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
4D Molecular Therapeutics, Inc. (FDMT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1277478) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms